The Blood Grouping Reagents Market in Latvia has experienced a steady decline from 2013 to 2023, with a market size value decreasing from 1.8973 million USD in 2013 to 1.6206 million USD in 2023. In 2023, the market size stood at 1.6206 million USD. The year-on-year variations over the last two years were -0.7% and -0.69%, indicating a continued decline. The compound annual growth rate (CAGR) over the last five years shows an average yearly decrease of -0.71%.
Future trends to watch for include potential market stabilization or growth from technological advances in blood grouping techniques or increased healthcare spending. Monitoring policy changes and healthcare initiatives in Latvia could also provide insights into future market developments.
